Novo Integrated Sciences EBIT

The latest EBIT for NVOS is $-1.6M as of August 2024. That compares with $-7.9M in the prior-year period — up 79.1% year over year. That is below the Industrials sector average of $40B. Investors often review this figure alongside Novo Integrated Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, NVOS's EBIT moved from $-7.9M to $-1.6M — a 79.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Novo Integrated Sciences's operating scale or balance-sheet position.

Against Industrials companies, NVOS currently prints $-1.6M for EBIT, while the sector average sits near $40B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Novo Integrated Sciences's growth, margins, and balance sheet.

A EBIT figure of $-1.6M for NVOS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Industrials average is about $40B. Explore the charts below for those layers of context.

After noting NVOS's EBIT ($-1.6M), review year-over-year change from $-7.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.